Skip to main content
Top
Published in: Supportive Care in Cancer 11/2018

01-11-2018 | Commentary

The application of neuromuscular electrical stimulation (NMES) in cancer rehabilitation: current prescription, pitfalls, and future directions

Authors: Dominic O’Connor, Brian Caulfield

Published in: Supportive Care in Cancer | Issue 11/2018

Login to get access

Abstract

The plethora of treatment complications associated with cancer can be offset by regular exercise participation; however, adherence to current guidelines is poor, in particular in those unable or not allowed to participate in voluntary exercise due to their underlying disease. Alternative therapies such as neuromuscular electrical stimulation (NMES) are promising although previous results in cancer survivors have been equivocal. This is likely in response to methodological issues such as inappropriate NMES prescription. Therefore, the aim of this commentary is to propose three key areas which should be addressed to increase NMES effectiveness in cancer rehabilitation; (1) NMES exercise should target both the neuromuscular and cardiovascular systems through low- and high-frequency modalities, (2) technological advancements such as mobile app-based systems should be leveraged to improve at-home monitoring of home-based NMES exercise, and (3) prescription and progression should follow the fundamental principles of exercise to overcome the heterogeneity in daily physiological, functional, and psychological factors faced by survivors. Addressing these three key areas in future studies may help improve NMES exercise effectiveness and accelerate patient rehabilitation.
Literature
3.
go back to reference Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen V, Schwartz AL, American College of Sports Medicine (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426CrossRef Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen V, Schwartz AL, American College of Sports Medicine (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426CrossRef
8.
go back to reference Cenik F, Schoberwalter D, Keilani M, Maehr B, Wolzt M, Marhold M, Crevenna R (2016) Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators. Wien Klin Wochenschr 128:802–808CrossRef Cenik F, Schoberwalter D, Keilani M, Maehr B, Wolzt M, Marhold M, Crevenna R (2016) Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators. Wien Klin Wochenschr 128:802–808CrossRef
11.
13.
go back to reference Minogue CM, Caulfield BM, Reilly RB (2007) What are the electrical stimulation design parameters for maximum VO 2 aimed at cardio-pulmonary rehabilitation? In: Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings. pp 2428–2431 Minogue CM, Caulfield BM, Reilly RB (2007) What are the electrical stimulation design parameters for maximum VO 2 aimed at cardio-pulmonary rehabilitation? In: Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings. pp 2428–2431
15.
18.
go back to reference Chughtai M, Piuzzi N, Yakubek G, Khlopas A, Sodhi N, Sultan AA, Nasir S, Yates BST, Bhave A, Mont MA (2017) Use of an app-controlled neuromuscular electrical stimulation system for improved self-management of knee conditions and reduced costs. Surg Technol Int 31:221–226PubMed Chughtai M, Piuzzi N, Yakubek G, Khlopas A, Sodhi N, Sultan AA, Nasir S, Yates BST, Bhave A, Mont MA (2017) Use of an app-controlled neuromuscular electrical stimulation system for improved self-management of knee conditions and reduced costs. Surg Technol Int 31:221–226PubMed
Metadata
Title
The application of neuromuscular electrical stimulation (NMES) in cancer rehabilitation: current prescription, pitfalls, and future directions
Authors
Dominic O’Connor
Brian Caulfield
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4269-z

Other articles of this Issue 11/2018

Supportive Care in Cancer 11/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine